{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:59:41Z","timestamp":1790182781651,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"European Union 7th Framework Program","award":["FP7\/2012"],"award-info":[{"award-number":["FP7\/2012"]}]},{"name":"SWITCH-HD","award":["324495"],"award-info":[{"award-number":["324495"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.01.029","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T14:00:21Z","timestamp":1485784821000},"page":"260-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels"],"prefix":"10.1016","volume":"117","author":[{"given":"Libo","family":"Yu-Taeger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Stricker-Shaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.01.029_bib1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddq018","article-title":"Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis","volume":"19","author":"Becanovic","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib2","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","article-title":"Huntingtin modulates transcription, occupies gene promoters in\u00a0vivo, and binds directly to DNA in a polyglutamine-dependent manner","volume":"28","author":"Benn","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00691525","article-title":"Neuropathological changes of the nucleus accumbens in Huntington's chorea","volume":"55","author":"Bots","year":"1981","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib4","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/8.9.1647","article-title":"Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin","volume":"8","author":"Boutell","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib5","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib6","doi-asserted-by":"crossref","first-page":"41452","DOI":"10.1074\/jbc.M303354200","article-title":"Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease","volume":"278","author":"Busch","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"issue":"Suppl 2","key":"10.1016\/j.neuropharm.2017.01.029_bib8","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2105-13-S2-S11","article-title":"Fold change and p-value cutoffs significantly alter microarray interpretations","volume":"13","author":"Dalman","year":"2012","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib9","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/pr900248y","article-title":"Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics","volume":"8","author":"Dowell","year":"2009","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib10","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2009.066399","article-title":"Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors","volume":"46","author":"Futter","year":"2009","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib12","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington's disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","article-title":"A\u00a0protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease","volume":"15","author":"Goehler","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib14","first-page":"838","article-title":"Screening for amyloid aggregation by semi-denaturing detergent-agarose gel electrophoresis","volume":"17","author":"Halfmann","year":"2008","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins","volume":"24","author":"Huang","year":"1998","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib17","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","article-title":"Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription","volume":"277","author":"Kegel","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1101\/pdb.prot4558","article-title":"Native agarose gel electrophoresis of multiprotein complexes","volume":"2011","author":"Kim","year":"2011","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neurobiolaging.2011.02.015","article-title":"Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons","volume":"33","author":"Kraft","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib21","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI57413","article-title":"Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease","volume":"121","author":"Labbadia","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib22","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease","volume":"285","author":"Landles","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/78054","article-title":"Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity","volume":"25","author":"Li","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib24","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","article-title":"Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice","volume":"21","author":"Li","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1101\/gad.8.9.995","article-title":"A\u00a0mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA\u2013promoter DNA complex formation","volume":"8","author":"Lieberman","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/glia.10261","article-title":"Microglia density decreases with age in a mouse model of Huntington's disease","volume":"43","author":"Ma","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib29","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib30","first-page":"78","article-title":"Plasmapheresis in the treatment of rapidly progressing glomerulonephritis","volume":"61","author":"Milovanov","year":"1989","journal-title":"Ter. arkhiv"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib31","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0076-6879(06)12008-X","article-title":"Imaging polyglutamine deposits in brain tissue","volume":"412","author":"Osmand","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20090908","article-title":"G-protein-coupled-receptor kinases mediate TNF\u03b1-induced NF\u03baB signalling via direct interaction with and phosphorylation of I\u03baB\u03b1","volume":"425","author":"Patial","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib34","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/47260","article-title":"EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF","volume":"402","author":"Prenzel","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib36","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1074\/jbc.M511648200","article-title":"Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective","volume":"281","author":"Qiu","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0026-895X(24)23050-9","article-title":"Nerve growth factor stimulation of p42\/p44 mitogen-activated protein kinase in PC12 cells: role of G(i\/o), G protein-coupled receptor kinase 2, beta-arrestin I, and endocytic processing","volume":"60","author":"Rakhit","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0968-0004(91)90164-Q","article-title":"The complexities of eukaryotic transcription initiation: regulation of preinitiation complex assembly","volume":"16","author":"Roeder","year":"1991","journal-title":"Trends biochem. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jnnp.48.5.422","article-title":"Neuronal distribution in the putamen in Huntington's disease","volume":"48","author":"Roos","year":"1985","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib40","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1523\/JNEUROSCI.23-09-03597.2003","article-title":"Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons","volume":"23","author":"Ryu","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","article-title":"Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation","volume":"15","author":"Schaffar","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/79139","article-title":"Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription","volume":"26","author":"Shimohata","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib44","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib45","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mad.2005.09.012","article-title":"Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?","volume":"127","author":"Squitieri","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib48","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib50","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddq548","article-title":"In\u00a0vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons","volume":"20","author":"Thomas","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","article-title":"Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease","volume":"395","author":"Weiss","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib53","doi-asserted-by":"crossref","first-page":"34235","DOI":"10.1074\/jbc.M102463200","article-title":"TATA-binding protein-associated factors enhance the recruitment of RNA polymerase II by transcriptional activators","volume":"276","author":"Wu","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib54","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","article-title":"A\u00a0novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease","volume":"32","author":"Yu-Taeger","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib55","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","article-title":"Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice","volume":"11","author":"Yu","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2202-9-38","article-title":"Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.029_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.01.029_bib58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:49:28Z","timestamp":1758437368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":58,"alternative-id":["S0028390817300308"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.029","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}